Recent News

• 02.26.2026 - Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
• 02.20.2026 - Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
• 11.14.2025 - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
• 08.14.2025 - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.08.2025 - BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update
• 07.17.2025 - BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB

Recent Filings

• 02.27.2026 - 8-K Current report
• 02.13.2026 - 8-K Current report
• 01.09.2026 - 8-K Current report
• 11.14.2025 - EX-99.1 EX-99.1
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - 8-K Current report
• 11.06.2025 - 8-K Current report
• 10.09.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 08.14.2025 - 8-K Current report
• 08.14.2025 - EX-99.1 EX-99.1